By Jaclyn Jaeger2019-03-12T15:22:00
Covidien has agreed to pay $17.5 million for violations of the False Claims Act by providing free or discounted practice development and market development support to physicians in California and Florida to induce purchases of Covidien products, the Department of Justice announced.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2019-04-26T20:03:00Z By Jaclyn Jaeger
Pharmaceutical companies Astellas and Amgen will pay a total of $124.75 million to resolve allegations that they violated the False Claims Act by illegally paying the Medicare co-pays for their own high-priced drugs.
2026-01-13T20:05:00Z By Oscar Gonzalez
Two months after the U.S. Consumer Financial Protection Bureau proposed a rule change to narrow anti-discrimination requirements for lenders, it has reversed previous guidance on noncitizen customers looking to borrow.
2026-01-13T20:05:00Z By Adrianne Appel
The U.S. Securities and Exchange Commission dropped its case against Rio Tinto’s former chief financial officer, who has battled charges for eight years.
2026-01-12T13:55:00Z By Adrianne Appel
The owner of a medical supply company allegedly billed federal health programs $30 million for items that were unnecessary and tainted by kickbacks, according to the Department of Justice (DOJ).
2026-01-09T17:41:00Z By Adrianne Appel
A former TD Bank assistant branch manager in New York was instrumental in helping a $653 million drug money laundering operation, known as “David’s Network,” wash dirty money through the bank, the U.S. Department of Justice announced Tuesday.
2026-01-06T17:38:00Z By Adrianne Appel
Teledyne will pay more than $1.5 million to settle allegations it supplied electronic parts to the Navy that deviated from specifications, a violation of the False Claims Act (FCA). But its cooperation with prosecutors earned it a credit, according to the U.S. Department of Justice (DOJ).
Site powered by Webvision Cloud